# Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?

> **NCT00159588** · NA · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 64 (actual)

## Conditions studied

- Headache

## Interventions

- **DRUG:** Betablockers or other preventive drugs based on primary headache type

## Key facts

- **NCT ID:** NCT00159588
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2006-11
- **Final completion:** 2007-12
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2022-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00159588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00159588, "Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00159588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*